Loading company…
Tempus AI is a Chicago company that uses AI-driven data analysis, genomic profiling and software to support precision medicine.
Founded in 2015 and headquartered in Chicago, US, Tempus AI, Inc. offers genomic profiling, algorithmic tests and software, including Tempus Hub and Tempus One, to help oncologists and healthcare systems make treatment decisions. Revenue comes from subscriptions and partnerships with healthcare providers. For 2024 the company reported USD 693.40 mn in revenue and USD -647.10 mn in EBITDA. In June 2024 it raised USD 410.70 mn in an IPO on the New York Stock Exchange, selling 11.1 million shares at USD 37 each.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in